IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus
Clinical trial NCT04400994 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04400994
- Sponsor
- The University of Hong Kong
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2025-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.